Survival of immature neurons is regulated by Bcl-x L , as targeted disruption of bcl-x significantly increases cell death in vivo and in vitro. Death of cultured bcl-x-deficient and wildtype telencephalic cells can be prevented by fetal calf serum or chemically-defined medium (ITS), suggesting trophic factors in these media potentiate survival through a pathway independent of Bcl-x L . Addition of trophic factors to basal medium revealed that insulin and insulin-like growth factors (IGFs), but not other trophic factors, reduced apoptosis of wild-type and bcl-x-deficient telencephalic cells. Antibodies raised against IGF-I receptors and wortmannin both attenuated the effects of IGF-I, indicating survival was mediated by IGF-I receptors and phosphatidylinositol 3'-kinase signaling, whereas effects of ITS were only partially reduced by these agents. The survival promoting effects of ITS were reduced in cells lacking both bcl-x and bcl-2, indicating Bcl-2 plays a supportive role to Bcl-x L in maintaining telencephalic cell survival. Furthermore, the ratio of expression of the pro-apoptotic bax gene to the anti-apoptotic bcl-2 gene was reduced in bcl-x-deficient cultures grown in ITS, suggesting that the interaction between these bcl-2 family members may, in part, regulate a Bcl-x L independent survival pathway. Finally, the pro-apoptotic bad gene does not appear to play a role in these interactions as targeted disruption of bad did not alter apoptosis in telencephalic cultures.
Introduction
Significant numbers of cells are eliminated by programmed cell death (PCD) during nervous system development, with over 50% of neurons dying in some regions (Oppenheim, 1991) . This death typically occurs by the process of apoptosis (Wyllie et al, 1980; Clarke, 1990) . Classic studies of the nervous system have examined a period of PCD when neurons compete for limited amounts of trophic factors released by target tissues (Purves, 1986; Cowan et al, 1984; Levi-Montalcini, 1966; Oppenheim, 1991) . However, a number of studies have demonstrated that widespread apoptosis occurs prior to target innervation in populations of immature neurons and neural precursor cells (Thomaidou et al, 1997; Galli-Resta and Ensini, 1996; Blaschke et al, 1996; Homma et al, 1994; Acklin and van der Kooy, 1993; Lance-Jones, 1982; Maruyama and D'Agostino, 1967) . Although these cells are not yet dependent upon target-derived trophic factors, the possibility that survival of immature neurons and/or progenitor cells may be enhanced by non-target-derived trophic factors needs to be examined.
One gene that plays an important role in regulating survival of immature neurons prior to target innervation is bcl-x. Bcl-x is a member of a family of proteins which share sequence homology with Bcl-2 (Merry and Korsmeyer, 1997; Craig, 1995; Reed, 1994) . Although bcl-x can be alternatively spliced into bcl-x L or bcl-x S , only bcl-x L is expressed in the mouse CNS (Krajewski et al, 1994; Boise et al, 1993; Gonzalez-Garcia et al, 1994) . Bcl-x L prevents apoptosis of many cell types, including immune cells and post-mitotic neurons (Gonzalez-Garcia et al, 1995; Boise et al, 1993; Frankowski et al, 1995) . Targeted disruption of bcl-x significantly increases apoptosis of immature neurons throughout the central nervous system (CNS), indicating that Bcl-x L is necessary for the survival of these cells (Motoyama et al, 1995) .
Primary cultures of E12 telencephalic cells have become a useful model in defining molecules important for early neuronal survival. Similar to neuroepithelial cells in vivo, wild-type E12 telencephalic cells cultured in basal medium can differentiate into neurons and/or die by apoptosis (Shindler et al, 1997) . Furthermore, apoptosis in cultures of bcl-x-deficient (bcl-x 7/7 ) neurons significantly increases compared to wild-type cultures (Shindler et al, 1997; Roth et al, 1996) . Interestingly, apoptosis of wild-type and bcl-x 7/7 telencephalic cells is almost completely eliminated in cultures grown in basal medium supplemented with fetal calf serum (FCS) or in chemically-defined medium (ITS) containing a variety of compounds including insulin, transferrin, and selenium . These data suggest that factors present in these media promote survival of immature neurons.
In addition to Bcl-x L , other Bcl-2 gene family members are important in controlling cell survival. Members such as Bcl-2, Bcl-w, and Mcl-1 inhibit apoptosis and promote cell survival, whereas Bax, Bad, and Bak promote apoptosis (reviewed in Merry and Korsmeyer, 1997) . Some Bcl-2 family members can form heterodimers (Sato et al, 1994; Chittenden et al, 1995; Yin et al, 1994; Sedlak et al, 1995) , and the balance between anti-apoptotic and pro-apoptotic proteins is important in determining if a given signal results in apoptosis (Shindler et al, 1997; Krajewski et al, 1995; Oltvai and Korsmeyer, 1994; Oltvai et al, 1993; Sedlak et al, 1995) . Therefore, ITS and FCS may promote cell survival in vitro by regulating expression of the Bcl-2 gene family. For example, ITS and FCS may rescue bcl-x 7/7 telencephalic cells by promoting up-regulation of anti-apoptotic genes such as bcl-2 or down-regulation of pro-apoptotic genes such as bax.
In the present study, survival of E12 telencephalic cells treated with neurotrophic factors was examined. Potential signaling of these factors through activation of IGF-I receptors and phosphatidylinositol 3'-kinase (PI3K) was examined by treating cultures with antibodies raised against IGF-I receptors (a-IR 3 ) and wortmannin, a PI3K inhibitor. Cultures of bcl-2 7/7 /bcl-x 7/7 telencephalic cells were used to determine if ITS can maintain cell survival in the absence of bcl-2, and expression of bcl-2 and bax mRNA were compared between cultures grown in basal medium or ITS. Furthermore, the role of bad was assessed in cultures of bad 7/7 cells. Results indicate that IGF-I, IGF-II, and insulin reduce apoptosis of telencephalic cells, and that ITS medium may, in part, promote survival by altering the balance between bcl-2 and bax.
Results
ITS and FCS prevent apoptosis of wild-type and bcl-x-de®cient telencephalic cells Similar to results reported previously (Shindler et al, 1997) , telencephalic cultures from E12 wild-type embryos grown for 48 h in basal medium (DMEM) contained differentiating neurons as determined by cellular morphology and expression of MAP2, a neuronal marker (data not shown). Cultures also contained a baseline level of cell death as 27.4+1.5% of cells (from 24 embryos) were apoptotic ( Figure 1A ) as determined by condensed and fragmented chromatin staining with bisbenzimide. Cultures from bcl-x 7/7 mice (21 embryos) contained significantly more apoptotic cells (76.5+1.7% cells) ( Figure 1A ). Apoptosis of both wild-type and bcl-x 7/7 cells was significantly reduced in cultures grown in ITS or 1.0% FCS for 48 h ( Figure 1A ).
IGF receptor ligands promote telencephalic cell survival independent of Bcl-x L
Since ITS and FCS have a dramatic survival promoting effect on cultured bcl-x 7/7 telencephalic cells, the ability of a variety of known neurotrophic factors to activate a Bcl-x L independent anti-apoptotic pathway was examined. ITS contains a high Figure 1 Enriched media, insulin, and insulin-like growth factors promote survival of wild-type (bcl-x +/+ ) and bcl-x-deficient (bcl-x 7/7 ) E12 telencephalic cells in culture. (A) Chemically-defined medium containing insulin, transferrin, and selenium (ITS) and DMEM containing fetal calf serum (FCS) telencephalic cells ( Figure 1B) . Although IGF receptor ligands increased survival, apoptosis still occurred in approximately 50% of bcl-x 7/7 cells grown in supplemented media, suggesting that additional factors may promote survival of E12 bcl-x 7/7 telencephalic cells. The effects of a number of neurotrophic factors were tested using concentrations of factors shown previously to have maximal effects on other neuronal cells (Ip et al, 1994; Lin et al, 1993; Lindholm et al, 1996; Knusel et al, 1990; Widmer and Hefti, 1994 telencephalic cell survival (data not shown).
The above results suggest that IGF receptor ligands can promote telencephalic cell survival through a Bcl-x L independent process. To determine whether these factors promote survival in the presence of Bcl-x L , factors were added to wild-type telencephalic cell cultures and results were compared with those presented for bcl-x 7/7 cells. Similar to bcl-x 7/7 cultures, insulin and IGF-I significantly increased wild-type cell survival ( Figure 1C ). IGF-II failed to increase wild-type cell survival. NGF, BDNF, NT-3, NT-4/5, CNTF, GDNF, and EGF also failed to affect telencephalic cell survival (data not shown).
IGF-I promotes telencephalic survival through the IGF-I receptor and PI3K signaling IGF-I has been shown previously to promote survival in some neuronal systems by activating the IGF-I receptor and PI3K signaling pathway (Singleton et al, 1996a,b; Matthews and Feldman, 1996; D'Mello et al, 1997) . To determine if these pathways are similarly involved in IGF-I mediated survival of E12 telencephalic cells, cultures grown in 100 ng ml 71 IGF-I were treated with either 2 mg ml 71 a-IR 3 or 100 mM wortmannin, concentrations which have been used previously to block IGF-I receptor activation and PI3K, respectively (Matthews and Feldman, 1996; D'Mello et al, 1997) . Differences in apoptosis were not found among wild-type or bcl-x 7/7 E12 telencephalic cultures grown in DMEM, DMEM and a-IR 3 or DMEM and wortmannin (data not shown). Cultures of bcl-x 7/7 cells grown in the presence of both IGF-I and either a-IR 3 or wortmannin contained significantly more apoptosis than cultures grown in IGF-I alone (P40.05), whereas levels of apoptosis were not different from cultures grown in unsupplemented DMEM (P50.05; Figure 2A ). Similarly, in wild-type cultures there were no differences in apoptosis between cultures grown in unsupplemented DMEM and cultures treated with both IGF-I and a-IR 3 or with IGF-I and wortmannin (P50.05 Figure 2A ).
ITS contains high concentrations of insulin that may be able to activate IGF-I receptors. To determine if IGF-I receptor activation and PI3K signaling are also involved in ITS mediated telencephalic survival, wild-type and bcl-x 7/7 cultures grown in ITS were treated with a-IR 3 or wortmannin. bcl-x 7/7 cultures grown in ITS supplemented with a-IR 3 or wortmannin contained significantly more apoptotic cells than cultures grown in unsupplemented ITS (P40.05; Figure 2B ). Wild-type ITS cultures treated with a-IR 3 or wortmannin also showed a tendency toward increased apoptosis as compared to ITS cultures, but this difference was not statistically significant (P50.05; Figure 2B ). However, apoptosis was still significantly lower in both wild-type and bcl-x 7/7 cultures grown in ITS with a-IR3 or wortmannin as compared to cultures grown in DMEM (P40.05; Figure 2B ).
bcl-2 promotes survival of bcl-x 7/7 telencephalic cells in ITS Insulin, IGF-I, and IGF-II reduced apoptosis of E12 bcl-x 7/7 telencephalic cells, although ITS and FCS appeared more effective in promoting cell survival. In the absence of Bcl-x L , other anti-apoptotic members of the Bcl-2 family might promote telencephalic cell survival. We hypothesized that ITS may reduce apoptosis of E12 telencephalic cells by regulating bcl-2, which could then function in place of Bcl-x L to promote cell survival. Mice carrying a targeted disruption of bcl-2 were bred to bcl-x-deficient mice to test this possibility. Double heterozygous (bcl-x +/7 /bcl-2 +/7 ) mice were raised and interbred to generate bcl-x 7/7 /bcl-2 7/7 embryos. Wildtype (bcl-x +/+ /bcl-2 +/+ ) and bcl-2-deficient (bcl-x +/+ /bcl-2 7/7 ) cultures grown in DMEM did not contain differing amounts of apoptosis ( Figure 3A) . The increased apoptosis in bcl-xdeficient (bcl-x 7/7 /bcl-2 +/+ ) cultures was also observed in double-deficient (bcl-x 7/7 /bcl-2 7/7 ) cultures ( Figure 3A ). Furthermore, apoptosis in cultures generated from mice carrying a single copy of either bcl-x or bcl-2 did not differ as compared to cultures from mice carrying two copies of the respective gene (data not shown).
Cultures grown in ITS contained significantly fewer apoptotic cells than those grown in DMEM (Figure 3) . In ITS, the number of apoptotic cells was not different in cultures generated from bcl-x +/+ /bcl-2 +/+ , bcl-x +/+ /bcl-2 7/7 , or bcl-x 7/7 /bcl-2 +/+ mice ( Figure 3B ). Although ITS significantly reduced apoptosis in bcl-x 7/7 /bcl-2 7/7 cultures as compared to cultures grown in DMEM, survival promoting effects of ITS were attenuated by disruption of bcl-2. Cultures of bcl-x 7/7 /bcl-2 7/7 cells grown in ITS contained significantly more apoptotic cells than either wild-type or bcl-x 7/7 / bcl-2 +/+ cultures ( Figure 3B ), indicating bcl-2 expression contributes to the Bcl-x L independent survival pathway observed in bcl-x 7/7 telencephalic cells grown in ITS.
The ratio of bcl-2 to bax is increased in E12 telencephalic cultures grown in ITS
The reduced ability of ITS to promote survival of bcl-x 7/7 cells lacking bcl-2 suggests that ITS may exert its effects by regulating expression of bcl-2 family members. Expression of the anti-apoptotic bcl-2 gene and the pro-apoptotic bax gene was examined. bax has been shown previously to interact with bcl-x to promote survival of E12 telencephalic cultures (Shindler et al, 1997) . Levels of bcl-2 and bax mRNA were compared by semi-quantitative RT ± PCR using the constitutively expressed cyclophilin gene to normalize the relative amount of mRNA in each culture. In both wild-type ( Figure 4A ) and bcl-x 7/7 ( Figure 4B ) cultures, cyclophilin expression was higher in cultures treated with ITS as compared to cultures grown in DMEM, reflecting increased cell survival in enriched medium. In wild-type cultures, ITS increased the ratio of bcl-2 to bax mRNA to 1.35+0.08 that of cells grown in basal medium (from six embryos, P40.05) ( Figure 4A ). An increased ratio of bcl-2 to bax expression (1.44+0.09) was also observed for bcl-x 7/7 cells grown in ITS versus DMEM (three embryos, P40.05) ( Figure 4B ), suggesting that ITS alters bcl-2 and bax expression independent of the bcl-x gene. Interestingly, although an increased ratio of bcl-2 to bax expression was observed in both wild-type and bcl-x 7/7 cells grown in ITS, wild-type cells contained decreased expression of both bcl-2 and bax in ITS versus DMEM (P40.05) (75.8+6.7% and 56.1+3.5% for bcl-2 and bax, respectively). bcl-x 7/7 cells, however, showed no change in bcl-2 expression (P50.05) but decreased bax expression (P40.05) (104.8+12.3% and 73.5+8.7%, respectively). Expression of bcl-x mRNA was not significantly altered by ITS in wild-type cultures (P50.05) (87+16%), nor was it detected in bcl-x 7/7 cultures (Figure 4 ).
E12 telencephalic cell survival is not regulated by Bad
In addition to Bcl-x, Bcl-2, and Bax, other members of the Bcl-2 family may balance with these members to affect survival of embryos, four bcl-x 7/7 /bcl-2 +/+ embryos, and five bcl-x 7/7 /bcl-2 7/7 embryos telencephalic cells. In some cell types, Bad heterodimerizes with Bcl-x L and inhibits its anti-apoptotic effects . To determine if Bad regulates apoptosis of E12 telencephalic cells, cultures of wild-type, heterozygous, and bad-deficient cells were grown for 48 h in DMEM. No difference in apoptosis was found between bad +/+ (eight embryos), bad +/7 (13 embryos), or bad 7/7 (seven embryos) cultures (P50.05; Figure 5 ).
Discussion
The ability of ITS and FCS-supplemented DMEM to inhibit apoptosis of E12 telencephalic cells and this study) indicates that factors present in these media promote survival of immature telencephalic cells. Since ITS contains a high concentration of insulin, it was hypothesized that insulin was important in mediating cell survival. This study demonstrates that insulin and insulin-like molecules IGF-I and IGF-II can inhibit apoptosis of E12 telencephalic cells. These results are supported by other studies illustrating that both IGF-I and IGF-II promote survival in many neuronal systems (Lindholm et al, 1996; D'Mello et al, 1993; Neff et al, 1993; Aizenman and de Vellis, 1987) . The mechanism by which IGF-I mediates effects in other systems involves IGF-I receptor activation and PI3K pathways (Singleton et al, 1996a,b; Matthews and Feldman, 1996; D'Mello et al, 1997) , and results presented here indicate a similar mechanism is used by immature telencephalic cells. IGF-I, IGF-II, and IGF-I receptors are expressed in the CNS by the early developmental period studied (Bondy et al, 1990; Rotwein et al, 1988) , and activation of IGF-I receptors may therefore promote survival of immature telencephalic cells in vivo.
Although IGF receptor ligands reduced cell death, apoptosis was not reduced to the same extent as it was Figure 4 Analysis of bcl-2 family mRNAs in E12 telencephalic cells by reverse transcriptase polymerase chain reaction. Wild-type (bcl-x +/+ ) (A) and bcl-xdeficient (bcl-x 7/7 ) cells (B) were grown in DMEM or ITS, RNA was isolated, and cDNA was prepared. Cyclophilin and bcl-2 family mRNAs were amplified by PCR; products were separated on polyacrylamide gels, and visualized by autoradiography and phosphorimaging using ImageQuant software from Molecular Dynamics. Results shown are from single experiments and are representative of results observed from six bcl-x +/+ and three bcl-x 7/7 embryos Figure 5 bad deficiency does not alter apoptosis of E12 telencephalic cells. Wild-type (bad +/+ ), heterozygous (bad +/7 ), and bad-deficient (bad 7/7 ) telencephalic cells were isolated on E12 and grown for 48 h in DMEM. Cells were fixed, stained with bisbenzimide, and the number of abnormal, apoptotic nuclei was counted as a percentage of the total number of nuclei present (% apoptotic cells (Ghosh et al, 1994) , and NT-4/5 causes increased survival of developing striatal neurons (Garcia et al, 1992; Ardelt et al, 1994) . The inability of these factors to promote survival in the present study may reflect the fact that few studies have used telencephalic cells isolated as early as E12. Furthermore, in many studies telencephalic cells were grown in FCS-or ITS-supplemented media prior to assessment of the effects of neurotrophic factors. Previously reported neurotrophic factor responsiveness may be a property of maturing neurons. Addition of FCS or ITS may promote survival of precursor cells in vitro, resulting in differentiation and eventual responsiveness to neurotrophic factors. The failure of neurotrophic factors to rescue E12 telencephalic cells in the current study may therefore indicate that neural precursors and/or progenitor cells have not yet developed the ability to respond to these factors. The increased death of bcl-x 7/7 telencephalic cells as compared to wild-type cells demonstrates that these cells are kept alive by a pathway which is dependent on Bcl-x L . The ability of IGF receptor ligands and enriched media to promote survival of bcl-x 7/7 cells, however, indicates these factors can stimulate at least one Bcl-x L independent anti-apoptotic pathway. It has been shown that Bax interacts with Bcl-x L to regulate telencephalic cell survival in the Bcl-x L dependent pathway (Shindler et al, 1997) , but the potential role of other Bcl-2 family members in promoting Bcl-x L independent survival was not known. Death of immature telencephalic cells by both Bcl-x L dependent and independent pathways is mediated by members of the caspase family of cysteine proteases (Roth and Shindler, 1998) . Furthermore, this death occurs by an apoptotic process as evidenced not only by caspase activation, which occurs during apoptosis but not during necrosis (Armstrong et al, 1997) , but also by nuclear condensation and terminal deoxytransferase-mediated deoxyuridine triphosphate nick end-labeling (Shindler et al, 1997; Roth et al, 1996) , previously used markers of apoptosis (Deckwerth and Johnson, 1993; Gavrieli et al, 1992) . Results here indicate that trophic factor signaling can indeed prevent this apoptotic process even in the absence of Bcl-x L .
IGF-I signaling through the IGF-I receptor and PI3K may promote telencephalic cell survival through a pathway that is completely independent of the Bcl-2 family. Alternatively, this signaling pathway may directly regulate Bcl-2 gene family members. Furthermore, although ITS mediated survival was observed to be partially dependent on the IGF-I receptor and PI3K, ITS continued to exert a significant survival effect in the presence of a-IR 3 or wortmannin. Additional signaling pathways activated by ITS may circumvent the role of the Bcl-2 family or may directly regulate Bcl-2 family members. Although a signaling pathway that promotes survival by directly inhibiting the cell death machinery is most consistent with preventing death in response to an acute stimulus, the alternative hypothesis that ITS may also use a longer process of regulating bcl-2 gene family member expression needs to be considered. In the paradigm used in these studies, apoptosis occurs approximately 30 h after initial plating of cells, whereas the ITS media is added at time zero. This may provide sufficient time for ITS to alter gene expression and thereby affect the susceptibility of a cell to an apoptotic signal.
Members of the Bcl-2 family form homo-and heterodimers (Sato et al, 1994; Chittenden et al, 1995; Yin et al, 1994; Sedlak et al, 1995) , and the intracellular balance between pro-and anti-apoptotic members may ultimately determine the fate of a cell in response to a given signal (Krajewski et al, 1995; Oltvai and Korsmeyer, 1994; Oltvai et al, 1993; Sedlak et al, 1995) . For example, the ratio of anti-apoptotic Bcl-x L to pro-apoptotic Bax protein is important in regulating immature telencephalic neuron survival (Shindler et al, 1997) . The ability of ITS, insulin, and IGFs to reduce apoptosis of bcl-x 7/7 telencephalic cells therefore suggests that these factors may act to restore a favorable intracellular balance of Bcl-2 family members. IGF-I does alter levels of some Bcl-2 family proteins in cultured neuroblastoma cells (Singleton et al, 1996a) , indicating insulin-like molecules can alter the intracellular balance of Bcl-2 family members in some systems, although Bcl-2 family expression is not affected in other cell types rescued by IGF-I (Xu et al, 1997; Jung et al, 1996) .
The ability of ITS to promote E12 telencephalic cell survival in the absence of bcl-x depends, in part, on bcl-2 expression. Although ITS attenuated apoptosis in wildtype and bcl-x 7/7 cells, ITS could not prevent apoptosis of some bcl-x 7/7 cells lacking a functional bcl-2 gene. This result suggests that ITS requires bcl-2 to promote survival in at least a subpopulation of telencephalic cells, and is consistent with the possibility that ITS may restore a favorable balance between Bcl-2 family members. In previous studies, bcl-2 deficiency showed only subtle nervous system abnormalities in vivo (Nakayama et al, 1993 (Nakayama et al, , 1994 Veis et al, 1993) despite the fact that Bcl-2 is present at high levels in proliferating neuroepithelial cells (Merry et al, 1994; Novack and Korsmeyer, 1994 ) and overexpression of bcl-2 leads to increased brain weight and numbers of neurons in specific regions (Farlie et al, 1995; Martinou et al, 1994) . Taken together, these results suggest Bcl-2 plays a secondary role to Bcl-x L in the developing CNS, serving a redundant function to promote survival when bcl-x fails to be expressed.
Rescue of bcl-x 7/7 /bcl-2 7/7 telencephalic cells by ITS may be reduced if ITS normally acts to up-regulate bcl-2. Alternatively, ITS may alter expression of other bcl-2 gene family members and still require functional bcl-2 to maintain a favorable balance of anti-apoptotic proteins. Data support the latter hypothesis because ITS decreased expression of the pro-apoptotic bax gene, without up-regulating bcl-2, resulting in a small, yet significant increase in the ratio of bcl-2 to bax. In previous studies, the ratio of bcl-2 to bax was shown to directly correlate with cell survival (Oltvai et al, 1993) ; therefore, an increased bcl-2 to bax ratio may represent one mechanism by which ITS promotes telencephalic cell survival.
The relative proportion of bax decreased in both wildtype and bcl-x 7/7 cells, suggesting changes in bax resulted from treatment with ITS, rather than a cellular response to loss of bcl-x. The observation that bax is down-regulated by ITS assumes that levels of cyclophilin, a constitutively-active gene routinely used , remains constant within individual cells. Decreased levels of cyclophilin observed in DMEM versus ITS treated cultures may reflect the fact that many cells grown in DMEM were apoptotic. Unlike other systems used to study apoptosis, apoptotic cells in these low density telencephalic cultures are not removed by phagocytosis. As a result, the total number of cells does not change during the culture period such that DMEM and ITS cultures contain equivalent total cell numbers (Shindler et al, 1997) . Because apoptotic cells have reduced mRNA synthesis (Johnson et al, 1996; Deckwerth and Johnson, 1993) , the uncleared apoptotic cells in DMEM cultures most likely contribute reduced amounts of mRNA. Therefore, changes in expression observed in the current studies probably represent mRNA levels in viable cells, and strongly suggests that ITS can regulate bcl-2 family expression.
Although ITS promoted a statistically significant increase in the ratio of bcl-2 to bax, this change was still relatively small compared to the changes in this ratio seen to affect survival in other cell populations (Oltvai et al, 1993) . The ability of ITS to regulate Bcl-2 family expression in immature telencephalic cells therefore may only partially, if at all, contribute to its survival promoting ability. Furthermore, the current studies focused mainly on the expression of bcl-x, bcl-2, and bax because previous studies of expression and function have indicated roles for these family members in the developing telencephalon. The possible role of other Bcl-2 family proteins could further alter the balance between pro-and anti-apoptotic members. One such member, Bad, has been shown to block the anti-apoptotic function of Bcl-x L in some cell types . Bad does not, however, appear to be involved in regulating immature telencephalic cell survival because targeted disruption of bad did not cause any changes in apoptosis. Although a growing number of additional Bcl-2 family members have been identified, expression studies have not examined whether most of these genes are expressed in the E12 telencephalon. The current data presented indicate that ITS can at least affect expression of some bcl-2 family genes, and the overall effects on the balance between all family members will have to be addressed as new members are found to be expressed and play a role in the developing telencephalon.
In summary, E12 telencephalic cells used in this study represent a population of neural precursor cells and immature neurons that have not yet innervated target tissues. Thus, extensive PCD occurring during this early development does not result from competition for targetderived trophic factors. Results of this study suggest that these early cells may depend on non-target-derived trophic factors. The IGFs represent one family that mediates these effects, and does so by promoting a Bcl-x L independent survival pathway.
Materials and Methods

Trophic factors
Human recombinant IGF-I, IGF-II, and insulin, and purified EGF from mouse submaxillary glands were purchased from Sigma, St. Louis, MO, USA. Purified NGF 2.5S from mouse submaxillary glands and human recombinant GDNF were purchased from Alomone Labs, Jerusalem, Israel. Human recombinant CNTF, BDNF, NT-3, and NT-4 were generous gifts from Regeneron Pharmaceuticals, Tarrytown, NY, USA.
Generation and detection of bcl-x-, bcl-2-and bad-de®cient mice
The use of homologous recombination in ES cells to generate bcl-x 7/7 (Motoyama et al, 1995) and bcl-2 7/7 (Nakayama et al, 1993 (Nakayama et al, , 1994 mice has been described previously. bad 7/7 mice were also generated by homologous recombination in ES cells. bcl-x +/7 male and female mice were bred to generate wild-type, heterozygous, and bcl-x 7/7 embryos, and endogenous and disrupted genes were detected by PCR analysis of tail DNA extracts (Shindler et al, 1997) . Similarly, bad +/7 male and female mice were bred to generate wildtype, heterozygous, and bad 7/7 embryos, and endogenous and disrupted genes were detected by PCR. To generate bcl-x 7/7 /bcl-2 7/7 mice, heterozygous bcl-x +/7 and bcl-2 +/7 were first bred to yield bcl-x +/7 /bcl-2 +/7 double heterozygotes that were subsequently interbred. Endogenous and disrupted bcl-2 were also detected by PCR of tail DNA extracts (Nakayama et al, 1993) .
Primary telencephalic cultures
E12 telencephalic cells were dissociated as described previously (Shindler and Roth, 1996) . In short, embryos were removed on gestational day 12, telencephalic vesicles were isolated, and cells were dissociated in 0.01% trypsin with 0.004% EDTA (Sigma) and 0.001% deoxyribonuclease I (Sigma), followed by mild trituration with a fire-polished Pasteur pipette. Cells were washed and resuspended in basal media [DMEM; a 1 : 1 mix of Dulbecco's Modified Eagle Medium and Ham's F12 Medium (Life Technologies, Grand Island, NY, USA) with 14 mM sodium bicarbonate and 15 mM HEPES, pH 7.4].
Twenty-thousand cells were plated in each well of a 48 well tissue culture plate. Wells were precoated with 0.1 mg ml 71 poly-L-lysine (Sigma) and 0.1 mg ml 71 laminin (Sigma) prior to plating. Cells were incubated for 48 h in 5% CO 2 at 378C in DMEM alone, DMEM supplemented with neurotrophic factors or 1% FCS, or in ITS media [DMEM supplemented with 5 mg ml 71 insulin, 100 mg ml 71 transferrin, 30 nM selenium, 20 nM progesterone, 100 mM putrescine, 6 g/L glucose, and 2 mM glutamine (all chemicals from Sigma)]. For signaling studies, 2 mg ml 71 a-IR 3 (Oncogene Research Products, Cambridge, MA, USA) or 100 mM wortmannin (Sigma) was added to the culture media at the time of plating.
Bisbenzimide labeling and quanti®cation of apoptosis
After 48 h in vitro, cells were fixed for 20 min at room temperature in PBS with 4% paraformaldehyde. Cell nuclei were stained with a 0.04 mg ml 71 solution of bisbenzimide (Hoechst dye 33258; Sigma) in PBS. Cell counts were done as previously described (Shindler et al, 1997) . Briefly, numbers of total nuclei and abnormally condensed, fragmented (apoptotic) nuclei were counted in four random fields at 406 magnification for each well, and duplicate wells were counted for each culture condition. The percentage of apoptotic cells was calculated by dividing the number of apoptotic nuclei by the total number of nuclei. Significance was established using Kruskal-Wallis analysis of variance followed by Dunn's test for all pairwise multiple comparisons.
Isolation of total RNA
Total RNA was isolated using Ultraspec TM RNA isolation system (Biotecx Laboratories, Houston, TX, USA). After 48 h in vitro, plates were placed on ice and medium was gently aspirated and replaced with 300 ml Ultraspec TM RNA solution. Cells were lysed by trituration through a pipette tip. Lysates were transferred to 1.5 ml Eppendorf tubes on ice and lysates from duplicate cell cultures were combined (such that 40 000 cells were used in each condition). After 5 min, 120 ml chloroform was added to each tube, samples were mixed vigorously and incubated on ice for 5 min. Samples were spun 15 min at 13 500 r.p.m. at 48C and each aqueous phase was transferred to a new tube. RNA was precipitated with an equal volume of isopropanol for 51 h at 7208C. RNA was pelleted at 13 500 r.p.m. for 15 min, then washed twice with 70% EtOH. After the final wash, RNA was resuspended in 50 ml DEPC-treated water and stored at 7808C until used.
Semi-quantitative reverse-transcriptase polymerase chain reaction (RT ± PCR) cDNA was generated from 25 ml of each RNA sample using Ready-ToGo TM You-Prime First-Strand beads (Pharmacia, Uppsala, Sweden) following manufacturer's instructions. After heating RNA for 10 min at 658C, samples were chilled to 48C. Samples were then transferred to a tube with a Ready-To-Go bead containing Moloney Murine Leukemia Virus Reverse Transcriptase. After addition of 0.2 mg random hexamer primers (Boehringer Mannheim, Indianapolis, IN, USA), cDNA was synthesized at 378C for 60 min.
The bcl-2, bax, and bcl-x primer sequences were identical to those used previously (Greenlund et al, 1995) and generated 231, 129 and 337 bp products, respectively. The cyclophilin forward (5'-GGGTTCCTCCTTTCACAGA-3') and reverse (5'-GCCATCCAGC-CATTCAGTC-3') primers yielded a 226 bp fragment. Each PCR reaction used 0.8 ml of cDNA in a 20 ml solution containing 10 mM Tris-HCl, pH 8.3; 50 mM KCl; 1.5 mM MgCl 2 ; 0.1 mM each of dATP, dGTP, and dTTP; 0.05 mM dCTP; 0.5 mCi [a-32 P]-dCTP (NEN Life Sciences, Boston, MA, USA); and 0.4 U Taq polymerase (PerkinElmer, Norwalk, CT, USA), final concentrations. Each reaction also contained 2 mM cyclophilin primers or 0.8 mM bax, bcl-2, or bcl-x primers. After a hot start at 948C for 1 min, reactions were cycled at 948C for 1 min, 628C for 1 min, and 728C for 1 min. The number of PCR cycles was chosen so that product formation remained within a linear range Estus et al, 1994) . Cyclophilin was amplified for 22 cycles, bcl-2 for 27 cycles, bax for 25 cycles, and bclx for 27 cycles in a Perkin-Elmer GeneAmp PCR System 2400. PCR products were separated on an 8% polyacrylamide gel, dried, and visualized on a PhosphorImager using ImageQuant software for volume integration (Molecular Dynamics, Sunnyvale, CA, USA). Changes in the ratios of bax, bcl-2, or bcl-x expression divided by cyclophilin expression were examined by comparing ratios from DMEM cultures with products amplified from ITS cultures. Significance of changes in mRNA levels were determined using a Signed Ranks Test.
